Trial Profile
Pharmacokinetics and safety of famciclovir [Famvir; Novartis] oral pediatric formulation in children 1-12 years of age with varicella zoster infection
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Apr 2016
Price :
$35
*
At a glance
- Drugs Famciclovir (Primary)
- Indications Chickenpox
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Novartis
- 07 Oct 2005 New trial record.